Walmart’s latest brand and logo update has left some social media users baffled. On Jan. 13, the company announced in a press release on its website that it was launching a “comprehensive ...
The first direction Tuesday was given by Stefanie Spear, a deputy chief of staff at HHS who joined the agency this week, according to the Post. Spear was the press secretary for Robert F.
HHS Secretary Alex Azar listens at right. (AP Photo/Susan Walsh, file) President Donald Trump speaks to members of the press as Director Robert Redfield, right, looks at the headquarters of the ...
HHS Sec­re­tary nom­i­nee Robert F. Kennedy Jr. will di­vest his in­ter­ests in sev­er­al bio­phar­ma com­pa­nies, in­clud­ing CRISPR Ther­a­peu­tics and Drag­on­fly Ther­a ...
The memo, which was sent to agency leaders by acting HHS Secretary Dorothy Fink, outlines that the HHS agencies should refrain from sending any documents for publication in the Federal Register ...
Kennedy Jr., President-elect Donald Trump’s pick for HHS secretary, undergoes Senate confirmation. Kennedy’s confirmation hearings are still not scheduled, and he is facing bipartisan pressure ...
The Trump administration has put a freeze on many federal health agency communications with the public through at least the end of the month. In a memo obtained by The Associated Press, acting ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...
The Washington Post: Trump Team Taps Dorothy Fink To Serve As Interim HHS Secretary Incoming Trump officials have tapped Dorothy Fink, an endocrinologist and career civil servant, as the interim ...
The U.S. Department of Health and Human Services’ (HHS') Biomedical Advanced Research and Development Authority (BARDA) has been working with Moderna since 2023 to help develop mRNA vaccines ...
The U.S. Department of Health and Human Services (HHS) said in a press release that the funding will allow the pharmaceutical company to accelerate the development of an H5N1 mRNA influenza ...